BlackRock Capital Allocation Term Trust (NYSE:BCAT) Shares Sold by Amplius Wealth Advisors LLC

Amplius Wealth Advisors LLC lowered its position in BlackRock Capital Allocation Term Trust (NYSE:BCATFree Report) by 22.1% in the third quarter, Holdings Channel.com reports. The firm owned 28,665 shares of the company’s stock after selling 8,133 shares during the quarter. Amplius Wealth Advisors LLC’s holdings in BlackRock Capital Allocation Term Trust were worth $472,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also recently added to or reduced their stakes in the company. Eagle Rock Investment Company LLC purchased a new position in shares of BlackRock Capital Allocation Term Trust during the 1st quarter worth approximately $298,000. Truist Financial Corp acquired a new position in BlackRock Capital Allocation Term Trust during the second quarter worth $319,000. Virtu Financial LLC acquired a new stake in BlackRock Capital Allocation Term Trust in the fourth quarter valued at $315,000. Ironsides Asset Advisors LLC boosted its position in shares of BlackRock Capital Allocation Term Trust by 14.1% during the 1st quarter. Ironsides Asset Advisors LLC now owns 29,133 shares of the company’s stock worth $485,000 after purchasing an additional 3,606 shares in the last quarter. Finally, Oppenheimer & Co. Inc. grew its stake in shares of BlackRock Capital Allocation Term Trust by 18.6% during the 1st quarter. Oppenheimer & Co. Inc. now owns 29,180 shares of the company’s stock worth $486,000 after purchasing an additional 4,586 shares during the period. Institutional investors and hedge funds own 36.12% of the company’s stock.

Insider Activity

In related news, major shareholder Saba Capital Management, L.P. sold 14,973 shares of the company’s stock in a transaction that occurred on Thursday, September 19th. The stock was sold at an average price of $16.41, for a total value of $245,706.93. Following the sale, the insider now owns 16,302,733 shares in the company, valued at $267,527,848.53. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. In the last three months, insiders sold 616,314 shares of company stock worth $10,172,244.

BlackRock Capital Allocation Term Trust Trading Up 0.1 %

Shares of BCAT opened at $16.26 on Thursday. BlackRock Capital Allocation Term Trust has a 52-week low of $13.67 and a 52-week high of $17.18. The company has a 50-day simple moving average of $16.36 and a 200-day simple moving average of $16.26.

BlackRock Capital Allocation Term Trust Increases Dividend

The business also recently announced a monthly dividend, which will be paid on Thursday, October 31st. Shareholders of record on Tuesday, October 15th will be issued a $0.2871 dividend. The ex-dividend date of this dividend is Tuesday, October 15th. This is a boost from BlackRock Capital Allocation Term Trust’s previous monthly dividend of $0.10. This represents a $3.45 dividend on an annualized basis and a yield of 21.19%.

About BlackRock Capital Allocation Term Trust

(Free Report)

See Also

Want to see what other hedge funds are holding BCAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Capital Allocation Term Trust (NYSE:BCATFree Report).

Institutional Ownership by Quarter for BlackRock Capital Allocation Term Trust (NYSE:BCAT)

Receive News & Ratings for BlackRock Capital Allocation Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Capital Allocation Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.